Imipenem 500MG & Cilastatin 500MG Injection IP.

Imipenem 500 mg & Cilastatin 500 mg Injection IP
Broad-Spectrum Protection. Reliable Clinical Performance.

Deliver powerful, broad-spectrum antibacterial action with Imipenem & Cilastatin Injection IP—a trusted combination for the treatment of serious infections caused by susceptible bacteria. This dual-component formulation provides high efficacy while minimizing the risk of renal degradation of the active drug.

Product Highlights:

• Powerful Combination Therapy:
  Imipenem, a carbapenem-class antibiotic, offers potent activity against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria. Cilastatin acts as a renal dehydropeptidase-I inhibitor, protecting imipenem from enzymatic breakdown and extending its antibacterial action.

• Trusted in Critical Care:
  Widely used in hospitals and intensive care settings for managing complicated infections, including respiratory tract infections, intra-abdominal infections, urinary tract infections, and skin/soft tissue infections.

• Broad-Spectrum Efficacy:
  Effective against multidrug-resistant organisms, making it a key choice in empirical therapy while awaiting culture and sensitivity results.

• Proven Safety Profile:
  Clinically established dosing and tolerability in adults when administered under appropriate medical supervision.

Indications:
Indicated for the treatment of serious infections where other antibiotics may not be effective, including polymicrobial infections and those involving resistant pathogens.

Dosage:
Administered via intravenous infusion. Dosage and frequency as directed by the physician, based on infection type and patient condition.

Important Safety Information:
Use with caution in patients with a history of seizures, renal impairment, or hypersensitivity to beta-lactam antibiotics. Monitor for allergic reactions and CNS effects. Not recommended for use in pediatric patients without specific guidance.